Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACRS
CLYM
Add up to 3 more stocks
ACRS
Aclaris Therapeutics, Inc.
-9.31%
$3.87-0.40Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$540.83M
52W Range
$1.74 - $6.60
CLYM
Climb Bio, Inc.
-0.74%
$10.97-0.08Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$628.08M
52W Range
$1.54 - $18.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.34 | 2.62 |
| P/S Ratio | 65.80 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 73.3% | 0.0% |
| Operating Margin | -975.9% | 0.0% |
| Net Margin | -921.5% | 0.0% |
| ROE | -60.8% | -24.1% |
| ROA | -42.1% | -23.4% |
| ROIC | -57.0% | -26.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.46 | 31.45 |
| Quick Ratio | 3.46 | 31.45 |
| Debt/Equity | 0.00 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.